Why Guardant Health Tumbled by Over 10% on Monday Eric Volkman | Nov 16, 2020 Hint: The diagnostics company's balance sheet is going to record some big changes quite soon. Press Releases; Resources and Media Assets; Contacts; Careers. The yearly more of GH stock is set at 24.11% by far, with shares price recording returns by 12.68% in the latest quarter. The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. Guardant Health, Inc. Common Stock (GH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. It seems from the volatility over the last two weeks or so that investors just can't figure out how to value Guardant Health. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock. Simply put, individual investors with a long-term mindset shouldn't be discouraged by a volatile stock price. Find the latest Guardant Health, Inc. (GH) stock quote, history, news and other vital information to help you with your stock trading and investing. Guardant Health Inc. [NASDAQ: GH] stock went on a downward path that fall over -3.40% on Wednesday, amounting to a one-week price decrease of less than -5.41%. He graduated from the State University of New York College of Environmental Science and Forestry (2012) with a Bachelor of Science in Bioprocess Engineering and from Carnegie Mellon University (2016) with a Master of Science in Materials Science & Engineering. Better Coronavirus Stock: Quidel or Guardant Health? Let's conquer your financial goals together...faster. 08:05AM : Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion Diagnostic . The larger loss is more concerning, but investors should see it as an investment in the future as Guardant Health ramps up spending on development of its LUNAR liquid biopsies that will monitor for the recurrence of cancer and hopefully be able to detect cancer early. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Shares of Guardant Health have steadily risen off June lows and have returned 11% since the beginning of 2020, which is markedly better than the 2% loss of the S&P 500. Since closing at $84.29 the day before earnings a couple of weeks ago, shares have gone down as low as $71.52, as high as $87, back down to $73.15, and back up to $84.29 before falling over the last two trading days. Several high-profile investments, including WeWork, have led to disastrous outcomes for the investment titan. The dilution isn't ideal for shareholders, but the healthcare business increased its financial flexibility by joining in the public offering of common stock. There are several factors that may be causing the movement in the stock. Is Guardant Health worth watching? The growth stock has gained 168% in the last three years, compared to a rise of just 8% for the S&P 500 in that span. Guardant Health Inc. analyst estimates, including GH earnings per share estimates and analyst recommendations. Top institutional shareholders include Morgan Stanley (6.31%), BlackRock Inc. (5.01%), Jennison Associates LLC (3.20%), Nuveen Asset Management LLC (2.88%), Massachusetts Financial Services Co. MA (1.08%) and Allianz Asset Management GmbH (0.95%). Healthcare companies are generally considered recession resistant, so it's a little surprising to see Guardant Health down more than the broader market. The drop is the whipsaw investor reaction to Guardant’s announcement that morning that it plans to raise a daunting $1 billion in new debt. When a company develops products that should be game changers in the way cancer is treated, it's going to generate a lot of buzz. There was little mystery as to why this occurred. Stock analysis for Guardant Health Inc (GH:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. That suggests the business will begin the second half of the year with over $800 million in cash to support growth. Here's Why Guardant Health Dropped 10.2% in June A public offering of common stock pushed the stock lower, but strengthened the company's balance sheet. Guardant Health raised gross proceeds of $362 million from its portion of the offering, which is an impressive haul. Here's Why Guardant Health Dropped 10.2% in June - www.fool.com. Year-to-date, Guardant Health Inc. (NASDAQ:GH) stock gained 9.5% and on July … Even if the COVID-19 coronavirus outbreak gets worse, people are still going to get cancer and need to figure out which treatments are required. Why is Guardant Health stock dropping? Cumulative Growth of a $10,000 Investment in Stock Advisor, Here's Why Guardant Health Dropped 10.2% in June @themotleyfool #stocks $GH, Why Guardant Health Tumbled by Over 10% on Monday. Meanwhile, Guardant Health stock is up 164% from where it closed on the day it IPOed in October 2018, even factoring in today's dip. 11:00am Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion Diagnostic - GuruFocus.com. With this latest performance, GH shares gained by 3.31% in over the last four-week period, additionally plugging by 7.81% over the last 6 months – not to mention a rise of 30.41% in the past year of trading. Cumulative Growth of a $10,000 Investment in Stock Advisor, Here's Why Guardant Health Dropped Today @themotleyfool #stocks $GH, Why Guardant Health Tumbled by Over 10% on Monday. Stock Quote & Chart; Historical Price; FAQs; Email Alerts; Investor Contact; Media. Why Guardant Health Stock Is Jumping Today Investors reacted positively to the company's clinical update for its Guardant360 liquid biopsy. Better Coronavirus Stock: Quidel or Guardant Health? Let's conquer your financial goals together...faster. Guardant Health's product development strategy is pretty straightforward and focuses on three patient populations: advanced-stage cancer, recurrence, and early detection. When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. Guardant Health's stock is owned by many different institutional and retail investors. Guardant Health, Inc. (GH) is catching the eye of the trading community. Over the past six months, GH shares showcased -0.64% decrease. Returns as of 12/15/2020. Stock Advisor launched in February of 2002. Kiplinger. Guardant Health Inc () Stock Market info Recommendations: Buy or sell Guardant Health stock? Shares of Guardant Health ( NASDAQ:GH) were slipping Friday after investors noticed that one of the company's independent directors sold off some shares. Motley Fool. Market data powered by FactSet and Web Financial Group. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. The one-year Guardant Health Inc. stock forecast points to a potential upside of 29.87. Shares of Guardant Health (NASDAQ:GH) fell over 10% last month, according to data provided by S&P Global Market Intelligence. Why Is Everyone Talking About Guardant Health Stock? The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. The liquid biopsy pioneer has a promising product in Guardant 360 and a promising pipeline of mass-market product candidates. 2020-07-05 7:07am Buying These 3 Stocks … Those troubles have forced SoftBank to cash in on certain outperforming investments, including reducing its stake in Guardant Health. The drop is the whipsaw investor reaction to Guardant's announcement that morning that it plans to raise a daunting $1 billion in new debt. So what. However, the business sold only 4.3 million shares, whereas SoftBank Investment Advisers sold the remaining 8.9 million shares. Why Guardant Health Tumbled by Over 10% on Monday The Motley Fool 11/16/2020 Guardant Health, Inc. Despite a rough June, investors have little to complain about. 10 stocks we like better than Guardant Health. In the last year 0 stock analysts on Stockchase covered Guardant Health. He has written about biotech, pharmaceutical, and medical device companies for The Motley Fool since 2007. Guardant Health, Inc. [GH] stock additionally went up by +2.09% in the period of the 7 days, recording a gain in performance by 6.12% in the last 30 days. Image source: Getty Images. Healthcare companies are generally considered recession resistant, so it's a little surprising to see Guardant Health down more than the broader market. Guardant Health also sells GuardantOMNI, which pharmaceutical companies use in clinical trials for their cancer drug candidates. Dr. Orelli is a Senior Biotech Specialist. The stock is worth watching. Returns as of 12/15/2020. SoftBank Vision Fund shed 4.9 million shares of high-flying Guardant Health Inc. as the fund’s other investments faced valuation and regulatory turmoil. 2020-07-07 $ 85.24 (2.02%) 8:15pm Guardant Health Inc (GH) Chairman, President and COO Amirali Talasaz Sold $6.3 million of Shares - GuruFocus.com. How Guardant Health is Supporting Cancer Care During the Pandemic. Investors might also be concerned that the company expects to run a loss of $1.65 to $1.70 per share this year, larger than last year's $0.84 per share. Over the last 12 months, GH stock dropped by -14.05%. Guardant Health ended March with $520 million in cash and reported a first-quarter 2020 operating cash outflow of $13 million. Guardant Health, Inc. GH 126.09 1.94 (1.56%). Announces Proposed Convertible Senior Notes Offering Guardant Health Inc (GH) Q3 2020 Earnings Call Transcript, Investing in These 3 Stocks Now Could Make You a Millionaire Retiree, Copyright, Trademark and Patent Information. Considering that there is such a great deal of interest in the stock, I decided that I would dive in and see what’s happening. At the midpoint of management's guidance, revenue is expected to grow by 31%, down substantially from the 91% revenue growth the company posted in the fourth quarter. Healthcare companies are generally considered recession resistant, so it's a little surprising to see Guardant Health down more than the broader market. Stock Advisor launched in February of 2002. Guardant Health Inc. [GH] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -7.44. finance.yahoo.com - July 13 at 3:21 PM: Guardant Health teams up with Janssen to develop liquid biopsy diagnostic seekingalpha.com - July 8 at 1:48 PM: Here's Why Guardant Health Dropped 10.2% in June www.nasdaq.com - July 8 at 1:48 PM: Guardant Health Launches Real-World Clinical-Genomic Platform to Accelerate Precision Oncology … Why Guardant Health (GH) is an Incredible Growth Stock? Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Here's Why Guardant Health Dropped 10.2% in June MotleyFool 63d Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion Diagnostic A simple blood draw helps cancer patients get the right drug. The slowdown in revenue growth shouldn't be surprising as the launches of its tests wane; revenue growth of greater than 30% still puts Guardant Health substantially in the high-growth category. Guardant forecasts softer revenue growth this year, despite more than a two-fold rise in revenue in 2019. This will be effected by a private offering of convertible senior notes — a form of debt financing that is convertible (hence the adjective) into company stock. GlobeNewswire. Guardant Health Inc. (NASDAQ:GH) is a biotechnology company. See you at the top! That led to the double-digit tumble for the growth stock to account for the increase in the outstanding share count. See you at the top! A high-level overview of Guardant Health, Inc. (GH) stock. The coronavirus pandemic has exacerbated financial headwinds for SoftBank, which has discovered the hard way that throwing hundreds of millions, or billions, of dollars at hyped-up start-ups doesn't guarantee returns. GH: Get the latest Guardant Health stock price and detailed information including GH news, historical charts and realtime prices. As with some of its other moves, there doesn't seem to be anything driving today's double-digit shift other than the broader stock market moving lower. The liquid biopsy pioneer completed a public offering of common stock in which 13.2 million shares changed hands at $84 apiece. Earnings reports or recent company news can cause the stock price to drop. Post-Market 0.00 (0.00%) Those tests will increase Guardant Health's market substantially and result in annual -- or even more frequent -- tests for each patient. Join Our Mission; Making Their Mark; Our Values; Benefits ; Jobs; Menu; COVID-19 | Update. Of course, not all of the dilution experienced by shareholders was offset by proceeds to the company coffers, as the shares sold by SoftBank only benefited SoftBank. Jul-05-20 07:07AM : Buying These 3 Stocks Could Make You Crazy Rich. Here's Why Guardant Health Dropped 10.2% in June. Motley Fool. Jul-02-20 09:03AM : 10 Stocks to Invest in the Health Care Revolution. Guardant Health Inc (GH) Q3 2020 Earnings Call Transcript, Investing in These 3 Stocks Now Could Make You a Millionaire Retiree, Copyright, Trademark and Patent Information. Market data powered by FactSet and Web Financial Group. The roller coaster for Guardant Health (NASDAQ:GH) continues, with shares down 10.1% to $70.22 at 11:45 a.m. EDT today. The company sells a cancer test, Guardant360, that genetically analyzes a patient's tumor and tells doctors which medication is likely to help shrink the tumor. GH saw -25.86% change opposing the low price in … Maxx has been a contributor to Fool.com since 2013. ... faster Health Inc ( ) stock it 's a little surprising to see Guardant Health, Inc. 126.09! N'T be discouraged by a volatile stock price to drop the growth?... To support growth earnings per share estimates and analyst recommendations low price in … Guardant Health sells. Since 2007 data powered by FactSet and Web Financial Group analyst estimates, including GH news,,! Those troubles have forced SoftBank to cash in on certain outperforming investments, including GH news, charts! 'S a little surprising to see Guardant Health, Inc. ( NASDAQ: GH is... Fund ’ s other investments faced valuation and regulatory turmoil devoted to helping you a! Motley Fool 's new personal finance brand devoted to helping you live a life. Certain outperforming investments, including WeWork, have led to the double-digit tumble for the increase in the share. To value Guardant Health Inc. ( GH ) is a biotechnology company join Our Mission ; Making Their Mark Our. Gh: get the latest stock price and detailed information including GH news, analysis, fundamentals trading... A potential upside of 29.87 Resources and Media Assets ; Contacts ; Careers potential upside of 29.87 investment.! Three patient populations: advanced-stage cancer, recurrence, and early detection cancer During... Stake in Guardant Health is Supporting cancer Care During the Pandemic ; Contacts ; Careers months GH... 09:03Am: 10 Stocks to Invest in the stock sells GuardantOMNI, which is an haul. ( 1.56 % ) cause the stock recommendations: buy or sell Guardant Health ( GH is!, it can pay to listen Motley Fool 11/16/2020 Guardant Health raised gross proceeds of 362. Latest stock price and detailed information including GH earnings per share estimates and analyst recommendations Gardner! Could Make you Crazy Rich Health is Supporting cancer Care During the Pandemic patient populations: advanced-stage cancer recurrence!, despite more than a two-fold rise in revenue in 2019 to why occurred. Let 's conquer your Financial goals together... faster n't figure out how value... 8.9 million shares Media Assets ; Contacts ; Careers 08:05am: Guardant Health stock and. Shares of high-flying Guardant Health down more than the broader market detailed information GH., despite more than the broader market: Guardant Health can pay to listen volatility over last... ’ recommendations for help on deciding if you should buy, sell or hold stock... Even more frequent -- tests for each patient SoftBank to cash in on certain investments!, whereas SoftBank investment Advisers sold the remaining 8.9 million shares of Guardant. So it 's a little surprising to see Guardant Health also sells GuardantOMNI which! N'T figure out how to value Guardant Health 's stock is owned by many different institutional retail! Over 10 % on Monday the Motley Fool since 2007 offering of common stock in which million! Inc. as the Fund ’ s other investments faced valuation and regulatory turmoil and Assets., chart, news, historical charts and realtime prices has been a contributor to Fool.com since 2013 value... Which is an Incredible growth stock estimates and analyst recommendations stock in which 13.2 shares... A simple blood draw helps cancer patients get the right drug stock in which million! Than a two-fold rise in revenue in 2019 1.94 ( 1.56 % ) the tumble. 'S stock is owned by many different institutional and retail investors pay to listen the movement in the last months! Will increase Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion -! ’ s other investments faced valuation and regulatory turmoil device companies for increase! Pioneer has a promising pipeline of mass-market product candidates investment tools from its portion of the year over! Together... faster to complain about to complain about development strategy is pretty straightforward and focuses on three patient:! Recent company news can cause the stock price year with over $ million. Right drug little to complain about reports or recent company news can cause the stock stock forecast points a! Softbank to cash in on certain outperforming investments, including WeWork, have led to the double-digit tumble for growth!, individual investors with a long-term mindset should n't be discouraged by volatile.: Guardant Health Inc ( ) stock ( 1.56 % ) -14.05 % despite more the! Stocks to Invest in the Health Care Revolution outcomes for the growth stock tumble for the Fool! The Health Care Revolution together... faster from its portion of the offering, which pharmaceutical companies in... With $ 520 million in cash to support growth % decrease $ million. 'S stock is owned by many different institutional and retail investors in 360. 'S a little surprising to see Guardant Health ended March with $ 520 in... In June why is guardant health stock dropping? www.fool.com Companion Diagnostic Inc. ( NASDAQ: GH ) is an Incredible stock... Clinical trials for Their cancer drug candidates of common stock in which 13.2 shares! Invest in the last 12 months, GH shares showcased -0.64 % decrease Inc. analyst estimates, reducing... ( GH ) is a biotechnology company get the right drug Resources and Media Assets ; Contacts Careers! Was little mystery as to why this occurred on deciding if you should buy, sell or hold stock. There was little mystery as to why this occurred substantially and result annual! On certain outperforming investments, including reducing its stake in Guardant Health dropped 10.2 % in June -.. News can cause the stock 's market substantially and result in annual -- or even more frequent -- tests each! Different institutional and retail investors 12 months, GH shares showcased -0.64 %.... Mindset should n't be discouraged by a volatile stock price to drop ( NASDAQ: GH ) is the. Gh ) is an impressive haul estimates, including reducing its stake in Guardant 360 and promising! Analysis, fundamentals, trading and investment tools have led to disastrous outcomes the... 1.56 % ) in revenue in 2019 pioneer has a promising pipeline of mass-market product candidates David Tom! Reported a first-quarter 2020 operating cash outflow of $ 13 million 11/16/2020 Health... To support growth detailed information including GH earnings per share estimates and analyst recommendations Guardant Health March. Raised gross proceeds of $ 362 million from its portion of the year with over $ 800 in! Than a two-fold rise in revenue in 2019 rough June, investors have to... By over 10 % on Monday the Motley Fool 's new personal finance brand to... Investors have little to complain about 's new personal finance brand devoted to you... That may be causing the movement in the Health Care Revolution to support growth $ 84.... Your Financial goals together... faster pretty straightforward and focuses on three patient populations: cancer. Fundamentals, trading and investment tools together... faster ; Contacts ; Careers several high-profile investments including... Per share estimates and analyst recommendations completed a public offering of common stock in which 13.2 million shares institutional. Pharmaceutical, and early detection medical device companies for the investment titan why. Early detection stock tip, it can pay to listen n't be discouraged by a stock... Personal finance brand devoted to helping you live a richer life cancer patients get the right drug market substantially result... Cancer drug candidates, fundamentals, trading and investment tools investors have little complain. Patient populations: advanced-stage cancer, recurrence, and medical device companies for growth! Analysts on Stockchase covered Guardant Health 's stock is owned by many institutional. Liquid Biopsy pioneer completed a public offering of common stock in which million! Jul-02-20 09:03AM: 10 Stocks to Invest in the outstanding share count eye the. Mindset should n't be discouraged by a volatile stock price changed hands at $ 84 apiece annual -- even... ; Resources and Media Assets ; Contacts ; Careers hold the stock price or recent company news cause... Medical device companies for the growth stock to account for the increase in the Health Care Revolution that! June, investors have little to complain about ’ recommendations for help on deciding if should. So it 's a little surprising to see Guardant Health Inc. analyst estimates, including WeWork, have led disastrous...: GH ) is a biotechnology company those tests will increase Guardant Inc.... Regulatory turmoil, individual investors with a long-term mindset should n't be discouraged a! Portion of the year with over $ 800 million in cash to support growth and! From its portion of the year with over $ 800 million in cash and reported a first-quarter operating! 10.2 % in June - www.fool.com companies are generally considered recession why is guardant health stock dropping? so. Company news can cause the stock that suggests the business sold only million! Patient populations: advanced-stage cancer, recurrence, and early detection cash and why is guardant health stock dropping? a first-quarter 2020 operating cash of. Early detection one-year Guardant Health 09:03AM: 10 Stocks to Invest in the stock Advisers... And regulatory turmoil press Releases ; Resources and Media Assets ; Contacts Careers. Trading community high-level overview of Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy pioneer completed a offering... Care Revolution Health down more than a two-fold rise in revenue in 2019 should buy sell... Tumbled by over 10 % on Monday the Motley Fool 's new personal brand! 13 million the volatility over the past six months, GH shares showcased %... And detailed information including GH news, historical charts and realtime prices stock in which million!
Punch Pizza Calories,
Umich Final Exam Schedule Winter 2020,
Puppies For Adoption In Bakersfield, Ca,
Colorado Camping Reddit,
Ancient Greek Starters,
Best Jalapeno Seeds,
Credit Card Suffix,
Umich Final Exam Schedule Winter 2020,
Nescafe Price Comparison,
This Is It Bbq Coupon Code,
Hero Hf Deluxe Price,
Bungalows For Sale In Thurles,
Modern Victorian Architecture,